Oral prednisone as a risk factor for infections in children with asthma

Archives of Pediatrics and Adolescent Medicine

Volumn 150, Issue 1, 1996, Pages 58-63

  Grant, Cameron C ^a,c   Duggan, Anne K ^a   Santosham, Mathuram ^b   DeAngelis, Catherine ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE;

ADOLESCENT; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0030065614     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.1996.02170260062010     Document Type: Article

References (28)

1. Mukwaya G. Immunosuppressive effects and infections associated with corticosteroid therapy. Pediatr Infect Dis J. 1988;7:499-504.
2. Lepper MH. Prophylaxis in patients receiving adrenal steroid therapy J Chronic Dis. 1962;15:691-711.
3. Barnes PJ A new approach to the treatment of asthma N Engl J Med 1989; 321:1517-1527.
4. National Asthma Education Program, Expert Panel Report. Guidelines for the Diagnosis and Management of Acute Asthma Bethesda, Md: US Dept of Health and Human Services, National Institutes of Health; 1991.
5. Storr J, Barry W, Barrell E, Lenney W, Hatcher G. Effect of a single oral dose of prednisolone in acute childhood asthma Lancet. 1987;1:879-881
6. Tal A, Levy N, Bearman JE. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics. 1990;86:350-356
7. Harris JB, Weinberger MM, Nassif E, Smith G, Milavetz G, Stillerman A. Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators. J Pediatr 1987;110 627-633
8. Sahay JN, Chaterjee SS, Stanbridge TN. Inhaled corticosteroid aerosols and candidiasis. Br J Dis Chest 1979;73:164-168
9. Brown HM, Storey G. Beclomethasone diprionate steroid aerosol in treatment of perennial allergic asthma in children. BMJ. 1973;3:161-164.
10. Hemstreet MPB, Reynolds DW, Meadows J Jr Oesophagitis: a complication of inhaled steroid therapy. Clin Allergy. 1980;10:733-738.
11. Morton JR, Mihalas LS, Leung P, Strieder DJ Corticosteroids and malnutrition: Aspergillus lung abscess in an asthmatic child. Chest. 1980;78.667-669.
12. Lantner R, Rockoff JB, DeMasi J, Boran-Ragotzy R, Middleton E. Fatal varicella in a corticosteroid-dependent asthmatic child receiving troleandomycin. Allergy Proc. 1990;11.83-87
13. Silk HJ, Guay-Woodfield L, Perez-Atayde AR, Geha RS, Broff MD. Fatal varicella in steroid-dependent asthma. J Allergy Clin Immunol. 1988;81:47-51.
14. Kasper WJ, Howe P. Fatal varicella after a single dose of corticosteroids. Pediatr Infect Dis J. 1990;9:729-732
15. Grant CC, Duggan AK, DeAngelis C. Independent parental administration of prednisone in acute asthma: a double-blind, placebo controlled, crossover study. Pediatrics. 1995,96:224-229.
16. Norušis MJ/SPSS Inc. Statistical Package for the Social Sciences (SPSS). PC+ Statistics 4.0. Chicago, Ill: SPSS Inc; 1990.
17. Craddock CG. Corticosteroid-induced lymphopenia, immunosuppression, and body defense. Ann Intern Med. 1978,88:564-566
18. Meuleman J, Katz P The immunologic effects, kinetics and use of glucocorticoids. Med Clin North Am 1985,69:805-816.
19. Fauci AS, Dale DC. The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood. 1975;46:235-243.
20. Dale DC, Fauci AS, Guerry D, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man: hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest. 1975;56:808-813.
21. Dale DC, Fauci AS, Wolff SM. Alternate day prednisone: leukocyte kinetics and susceptibility to infections. N Engl J Med. 1974;291:1154-1158.
22. Boggs DR, Athens JW, Cartwrignt GE, Wintrobe MM. The effect of adrenal glucocorticosteroids upon the cellular composition of inflammatory exudates. Am J Pathol. 1964;44:763-773.
23. Fauci AS, Dale DC, Balow JE Glucocorticoid therapy mechanisms of action and clinical considerations. Ann Intern Med. 1976,84:304-315.
24. John TJ. Leukocytosis during steroid therapy. AJDC. 1966;111:68-70.
25. Shoenfield Y, Gurewich Y, Gallant LA, Pinkhas J. Prednisone-induced leukocytosis: influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med. 1981;71:773-778.
26. Food and Drug Administration Warning on varicella added to corticosteroid drug product labeling. JAMA. 1992;267:339.
27. Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short term, high-dose, systemic steroids in children with asthma the effect on the hypothalamic-pituitary-adrenal axis J Allergy Clin Immunol. 1987;80:81-87.
28. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983;309:265-268